Karyopharm Therapeutics (KPTI) PT Lowered to $5 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.11 | 52 Week High | $19.41 | |||
| Open | $0.11 | 52 Week Low | $4.83 | |||
| Day High | $0.11 | P/E | N/A | |||
| Day Low | $0.11 | EPS | $-2.74 | |||
| Volume | 1,722,531 | |||||
